Healthcare provider profile · identity verified

Bradley B Wozney, MD

Family Practice · DENMARK, WI · NPI 1225013675

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	110
Rosuvastatin Calcium	Rosuvastatin Calcium	288	79
Lisinopril	Lisinopril	257	74
Omeprazole	Omeprazole	218	61
Amlodipine Besylate	Amlodipine Besylate	181	44
Furosemide	Furosemide	180	48
Levothyroxine Sodium	Levothyroxine Sodium	179	45
Metoprolol Succinate	Metoprolol Succinate	171	48
Losartan Potassium	Losartan Potassium	142	42
Metformin Hcl Er	Metformin Hcl	132	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	37
Pantoprazole Sodium	Pantoprazole Sodium	116	30
Hydrochlorothiazide	Hydrochlorothiazide	115	36
Metformin Hcl	Metformin Hcl	101	27
Eliquis	Apixaban	99	22
Potassium Chloride	Potassium Chloride	99	20
Allopurinol	Allopurinol	95	24
Metoprolol Tartrate	Metoprolol Tartrate	88	17
Tramadol Hcl	Tramadol Hcl	84	23
Gabapentin	Gabapentin	83	17
Jardiance	Empagliflozin	77	18
Simvastatin	Simvastatin	75	20
Warfarin Sodium	Warfarin Sodium	73	17
Meloxicam	Meloxicam	63	26
Albuterol Sulfate Hfa	Albuterol Sulfate	60	25
Tamsulosin Hcl	Tamsulosin Hcl	56	22
Clopidogrel	Clopidogrel Bisulfate	55	15
Carvedilol	Carvedilol	54	16
Citalopram Hbr	Citalopram Hydrobromide	53	14
Donepezil Hcl	Donepezil Hcl	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	17
Fluticasone Propionate	Fluticasone Propionate	45	21
Sertraline Hcl	Sertraline Hcl	44	13
Buspirone Hcl	Buspirone Hcl	43	suppressed
Glipizide Er	Glipizide	43	14
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Ozempic	Semaglutide	40	11
Chlorthalidone	Chlorthalidone	38	11
Prednisone	Prednisone	37	24
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Trulicity	Dulaglutide	36	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	13
Glimepiride	Glimepiride	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Clonazepam	Clonazepam	25	suppressed
Famotidine	Famotidine	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Temazepam	Temazepam	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Cephalexin	Cephalexin	23	16
Glipizide	Glipizide	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Diazepam	Diazepam	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Atenolol	Atenolol	21	suppressed
Finasteride	Finasteride	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Primidone	Primidone	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Naproxen	Naproxen	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Digoxin	Digoxin	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Amoxicillin	Amoxicillin	14	11
Carbamazepine	Carbamazepine	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Zyprexa	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error